Glannaventa Competitors and Similar CompaniesClear all

Glannaventa's competitors and similar companies include iCAD, Guided Therapeutics, Oncovision and Spectrum Health.

	Glannaventa Glannaventa is a company that develops medical devices.	iCAD iCAD is a company that specializes in developing AI-based solutions for early detection and risk assessment of breast cancer.	Guided Therapeutics Guided Therapeutics is a medical technology company developing biophotonics solutions for the non-invasive detection of cancer.	Oncovision Oncovision is a provider of medical imaging devices used for the diagnosis and treatment of cancer.	Spectrum Health Spectrum Health is a not-for-profit, integrated, managed care health care organization.
Founding Date	Founding Date 2009	Founding Date N/A	Founding Date 1992	Founding Date 2003	Founding Date 1997
Type	Type Private	Type Public	Type Public	Type Private	Type Subsidiary
Tags	Tags Healthcare medical devices medical diagnostics medical imaging oncology	Tags Healthcare artificial intelligence medical diagnostics medical imaging oncology	Tags Healthcare medical devices medical imaging oncology	Tags Healthcare medical devices medical diagnostics medical imaging medtech oncology	Tags Healthcare medical diagnostics medical imaging oncology
Locations	Locations Bainbridge Island, US HQ	Locations Nashua, US HQ San Jose, US	Locations Peachtree Corners, US HQ	Locations València, ES HQ Boston, US	Locations Grand Rapids, US HQ
Employees	Employees 1	Employees 6738% decrease	Employees 10	Employees 24	Employees 12,253
Valuation ($)	Valuation ($) N/A	Valuation ($) 50.1 m	Valuation ($) 12 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $19.6m (FY, 2024)	Revenue (est.) $767k (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $3m (FY, 2024)	Cost of goods $196k (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $16.6m (FY, 2024)	Gross profit $571k (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income N/A	Net income ($5.6m) (FY, 2024)	Net income ($3.2m) (FY, 2025)	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 15m	Total funding raised $ 8.6m	Total funding raised $ 8.8m	Total funding raised N/A